We report on the generation of bright white luminescence through solid-state illumination of remote phosphors based on novel cycloplatinated N-heterocyclic carbene (NHC) compounds. Following a stepwise protocol we got the new NHC compound [{Pt(μ-Cl)(C(∧)C*)}2] (4) (HC(∧)C*-κC* = 1-(4-(ethoxycarbonyl)phenyl)-3-methyl-1H-imidazol-2-ylidene), which was used together with the related ones 4a (HC(∧)C*-κC*= 1-(4-cyanophenyl)-3-methyl-1H-imidazol-2-ylidene) and 4b (HC(∧)C*-κC*= 3-methyl-1-(naphthalen-2-yl)-1H-imidazol-2-ylidene) as starting materials for the synthesis of the new ionic derivatives [Pt(R-C(∧)C*) (CNR')2]PF6 (R = -COOEt, R' = t-Bu (5), Xyl (6); R = -CN, R' = t-Bu (7), Xyl (8); R(∧)C = Naph, R' = t-Bu (9), Xyl (10)). The X-ray structures of 6 and 8-10 have been determined. The photophysical properties of these cationic compounds have been studied and supported by the time-dependent-density functional theory (TD-DFT) calculations. The compounds 5, 8, and 9 have been revealed as the most efficient emitters in the solid state with quantum yields of 41%, 21%, and 40%, respectively. White-light remote-phosphors have been prepared just by stacking different combinations of these compounds and [Pt(bzq) (CN) (CN(t)Bu)] (R1) as blue (5, 8), yellow (9), and red (R1) components onto the same substrate. The CCT (correlated color temperature) and the CRI (color rendering index) of the emitted white-light have been tuned by accurately controlling the individual contributions.
The synthesis of 1-(4-cyanophenyl)-1H-imidazol(1) has been carried out by an improved method. Then, its corresponding imidazolium iodide salt, 2, has been used to prepare the N-heterocyclic carbene (NHC) cycloplatinated compound [{Pt(µ-Cl)(C^C*)} 2 ] (4) (HC^C*-κC*=1-(4-cyanophenyl)-3-methyl-1H-imidazol-2-ylidene)
New heteroleptic compounds of platinum(II)-containing cyclometalated N-heterocyclic carbenes, [PtCl(R-C^C*)(PPh)] [R-CH^C*-κC* = 3-methyl-1-(naphthalen-2-yl)-1H-imidazol-2-ylidene (R-C = Naph; 1A), 1-[4-(ethoxycarbonyl)phenyl]-3-methyl-1H-imidazol-2-ylidene (R = COEt; 1B), and [Pt(R-C^C*)(py)(PPh)]PF (py = pyridine; R-C = Naph, 2A; R = COEt, 2B], have been prepared and fully characterized. All of them were obtained as the trans-(C*,PPh) isomer in high yields. The selectivity of their synthesis has been explained in terms of the degree of transphobia (T) of pairs of ligands in trans positions. X-ray diffraction studies on both 2A and 2B revealed that only in 2A, containing a C^C* with a more extended π system, do the molecules assemble themselves into head-to-tail pairs through intermolecular π···π contacts. The photophysical properties of 2A and 2B and those of the related compounds [Pt(NC-C^C*)(PPh)L]PF [NC-CH^C*-κC* = 1-(4-cyanophenyl)-3-methyl-1H-imidazol-2-ylidene; L = pyridine (py; 2C), 2,6-dimethylphenylisocyanide (CNXyl; 3C), and 2-mercapto-1-methylimidazole (MMI; 4C)] have been examined to analyze the influence of the R substituent on R-C^C* (R-C = Naph; R = COEt, CN) and that of the ancillary ligands (L) on them. Experimental data and time-dependent density functional theory calculations showed the similarity of the electronic features associated with R-C^C* (R = CN, COEt) and their difference with respect to R-C^C* (R-C = Naph). All of the compounds are very efficient blue emitters in poly(methyl methacrylate) films under an argon atmosphere, with QY values ranging from 68% (2B) to 93% (2C). In the solid state, the color of the emission changes to yellowish-orange for compounds 2A (λ = 600 nm) and 3C (λ = 590 nm) because of the formation of aggregates through intermolecular π···π interactions. 2C and 3C were chosen to fabricate fully solution-processed electroluminescent devices with blue-light (2C), yellow-orange-light (3C), and white-light (mixtures of 2C and 3C) emission from neat films of the compounds as emitting layers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.